Senate Patent Bill Leaves Industry Still Wanting PTO Process Reforms
This article was originally published in The Pink Sheet Daily
Executive Summary
But Judiciary Committee Chairman Grassley, one of the bipartisan measure’s cosponsors, said he would try to address biopharma industry’s concerns about abuse of the inter partes review process.